Article
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
29 May 2018
Abstract excerpt
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related death in the world with a five-year survival rate of less than 5%. Not all PDAC are the same, because there exist intra-tumoral heterogeneity between PDAC, which poses a great challenge to personalized treatments for PDAC. METHODS: To dissect the molecular heterogeneity of PDAC, we performed a retrospective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
